Patent Analysis
Patent Analysis
Sale
The infertility diagnostics devices market was valued at USD 1.18 billion in 2023. It is expected to grow at a CAGR of 8.8% during the forecast period of 2024-2032 and attain a market value of USD 2.52 billion in 2032.
There has been a significant increase in the number of patent applications associated with infertility diagnostics devices and the market is driven by rising rates of infertility worldwide, which are caused by delayed parenthood, lifestyle changes, and environmental influences.
The Global Infertility Diagnostics Devices Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for global infertility diagnostics devices include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within infertility diagnostic device technologies.
High-resolution ultrasound and cutting-edge imaging technologies like 3D and 4D ultrasounds help detect conditions like fibroids and polycystic ovary syndrome (PCOS) by providing detailed images of the uterus, fallopian tubes, and ovaries. Therefore, such techniques have a significant impact on the patent landscape.
Medical instruments like infertility diagnostics devices are used to determine and assess the underlying causes of infertility in both men and women. By offering comprehensive insights into the structural, hormonal, and genetic factors that may contribute to infertility, they play a critical role in evaluating reproductive health and enabling individualized and successful treatment plans. These tools, which support precise infertility diagnosis and treatment planning, include imaging systems, prediction kits, and other testing technologies.
The infertility diagnostics devices market continues to evolve as societal trends that favor delaying parenthood for personal and professional reasons are becoming common. This has resulted in an increased incidence of infertility which raises the need for diagnostic tools. Also, the growing and strengthening of the healthcare infrastructures in developing nations makes infertility diagnostics more accessible, which propels market expansion significantly.
Increasing Product Launches is Expected to Boost the Market Growth
The infertility diagnostic devices patent landscape is driven by the increasing number of new product launches. This pattern is the result of the industry's continuous investment in R&D, which satisfies the expanding need for advanced diagnostic services. New products developed using innovative technologies prompt the manufacturers to file for patent applications and secure their technologies to assert market dominance. The accuracy and effectiveness of infertility assessments are improved by ongoing innovations and the introduction of cutting-edge diagnostic tools, which facilitate the diagnosis and successful treatment of infertility problems by medical professionals.
Growing Awareness and Acceptance is Expected to Propel the Infertility Diagnostic Devices Patent Industry
Market expansion has been greatly aided by rising public acceptance of infertility diagnostics and treatments. Increased societal acceptance, media attention, and educational initiatives are motivating more people and couples to seek infertility diagnoses and treatments.
With the increasing acceptance and innovation in technology, there has been an increase in patent grants rising from 225 patents in 2022 to 258 patents in 2023.
The report provides an in-depth analysis of the patents in this field by the following segmentation -
Breakup by Product Type
Breakup by Test Type
The breakup based on product type is broadly divided into imaging systems, ovulation prediction kits, sperm analysis systems and others. Imaging systems are further divided into ultrasound, MRI systems and others.
Ovulation prediction kits study the spike in luteinizing hormone (LH) in the urine that happens just before ovulation. This spike in hormones helps women plan when to undergo insemination to increase their chances of getting pregnant by indicating the most fertile days in their menstrual cycle. These kits are vital resources for reproductive health because they offer a precise and non-invasive way to track ovulation.
Detailed technological data will be provided for all specified segments classified in this report.
The United States is one of the leading jurisdictions for infertility diagnostics device patents, having around 11,300 patents. The presence of a well-established healthcare infrastructure, a robust legal framework and prominent research institutions engaged in innovations contributes to the patent landscape significantly.
Holding a significant chunk of the global population, China is another vital jurisdiction and is witnessing rapid growth in patent filings. The expanding healthcare landscape in the region contributes to the evolving research capabilities, thereby influencing a surge in patent applications.
Among the players with infertility diagnostics device patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
Genentech Inc
It is a leading biotechnology company committed to create and distribute cutting-edge therapies for a range of illnesses, including infertility. They are renowned for their contributions to diagnostic tools and biopharmaceuticals, which address pressing global health needs.
Abbott Lab
A multinational healthcare corporation well-known for offering a wide variety of medical equipment and diagnostic services, including infertility diagnostic solutions. Their unique reproductive health technologies are designed to offer precise and trustworthy testing to people who want to know more about and control their fertility.
Other companies include CooperSurgical, Inc., Vitrolife AB and Intin Inc., among others.
The Global Infertility Diagnostics Devices Patent Report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:
Scope of the Report | Details |
Analysis by Product Type |
|
Analysis by Test Type |
|
Key Players Mentioned |
|
Geographies Covered |
|
Global Infertility Treatment Devices Market
Global Infertility Drugs Market
Global Female Dysfunction Treatment Market
Global Sex Reassignment Surgery Market
Global Sexually Transmitted Diseases Testing Market
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Introduction
2 Executive Summary
3 Global Infertility Diagnostics Device Market Overview
3.1 Global Infertility Diagnostics Device Market Historical Value (2017-2023)
3.2 Global Infertility Diagnostics Device Market Forecast Value (2024-2032)
4 Global Infertility Diagnostics Device Market Segmentation
4.1 Global Infertility Diagnostics Device Market (2017-2032) By Product Type
4.1.1 Market Overview
4.1.2 Imaging Systems
4.1.2.1 Ultrasound
4.1.2.2 MRI Systems
4.1.2.3 Others
4.1.3 Ovulation Prediction Kits
4.1.4 Sperm Analysis Systems
4.1.5 Others
4.2 Global Infertility Diagnostics Device Market (2017-2032) by Test Type
4.2.1 Market Overview
4.2.2 Female Infertility Testing
4.2.2.1 Ovarian Reserve Testing
4.2.2.2 Hormonal Level Testing
4.2.2.3 Tubal Patency Test
4.2.2.4 Others
4.2.3 Male Infertility Testing
4.2.3.1 Semen Analysis
4.2.3.2 DNA Fragmentation
4.2.3.3 Other Sperm Function Test
4.3 Others Global Infertility Diagnostics Device Market (2017-2032) by Gender
4.3.1 Market Overview
4.3.2 Male
4.3.3 Female
4.4 Global Infertility Diagnostics Device Market (2017-2032) by End User
4.4.1 Market Overview
4.4.2 Hospitals
4.4.3 Fertility Clinics
4.4.4 Others
5 Global Market Dynamics
5.1 Market Drivers and Constraints
5.2 Porter’s Five Forces Analysis
5.3 PESTEL Analysis
5.4 Industry Events, Initiatives, and Trends
5.5 Value Chain Analysis
6 Global Infertility Diagnostics Device Patent Landscape Analysis
6.1 Patent Distribution by Publication Year
6.2 Patent Distribution by Application Year
6.3 Patent Distribution by Priority Year
6.4 Analysis by Type of Patent
6.4.1 Granted Patents
6.4.2 Patent Application
6.4.3 Amended Application
6.4.4 Search Report
6.5 Analysis by Legal Status
6.5.1 Active
6.5.2 Pending
6.5.3 Expired/Discontinued
6.6 Analysis by Patent Jurisdiction
6.7 Analysis by Patent Age
6.8 Analysis by Cooperative Patent Classification (CPC) Codes
6.9 Average Time to Publish a Patent
6.9.1 By Entities
6.9.2 By Jurisdiction
6.9.3 By Technology
6.10 Analysis by Type of Entity (Academic and Non-Academic)
6.11 Analysis by Top Applicants
6.12 Analysis by Top Inventors
7 Global Infertility Diagnostics Device Patent Analysis by Technology
7.1 Total Patents by Top Technologies
7.2 Time Evolution of Patents by Technology
7.3 Emerging Technologies
7.4 Patent Segmentation, By Product Type
7.4.1 Time Evolution by Number of Patents
7.4.2 Time Evolution by Number of Patent Families
7.4.3 Analysis by Type of Entity (Academic vs Non-Academic)
7.4.4 Analysis by Top Applicants
7.4.5 Analysis by Top Inventors
7.5 Patent Segmentation, By Test Type
*Complete technology list will be provided in the report.
8 EMR Patent Valuation Analysis
8.1 Assessment Methodology
8.2 High Value Patents
8.3 Medium Value Patents
8.4 Low Value Patents
9 Global Infertility Diagnostics Device – Top 10 Players Patent Analysis
9.1 Top 10 Entities by Number of Patents
9.2 Analysis by Publication Year
9.3 Analysis by Application Year
9.4 Analysis by Priority Year
9.5 Analysis by Type of Patent
9.6 Analysis by Jurisdiction
9.7 Analysis by Cooperative Patent Classification (CPC) Codes
9.8 Analysis by Source of Innovation
9.9 Analysis by Forward and Backward Citations
9.10 Analysis by Legal Status
9.11 Analysis by Patent Age
9.12 Analysis by Key Inventors
9.13 Entity Dynamics
9.13.1 Analysis by Type of Player (Academic vs Non-Academic)
9.13.2 Analysis by Collaboration
9.13.3 Analysis by Technology
9.13.4 Newcomers
9.13.4.1 Start-up Companies
9.13.4.2 Established Companies
10 Patent Profile of Key Players
10.1 Genentech Inc
10.1.1 Product Portfolio
10.1.2 Patent Portfolio by Patent Families
10.1.3 Time Evolution of Patents
10.1.4 Geographical Patent Coverage
10.1.5 Patent Analysis by Technology
10.1.6 Patent News and Developments
10.1.7 Financial Analysis
10.1.8 SWOT Analysis
10.2 Abbott Lab
10.3 CooperSurgical, Inc
10.4 Vitrolife AB
10.5 Intin Inc
11 Future Trends
12 Global Infertility Diagnostics Device Landscape (Additional Insight)*
12.1 Global Infertility Diagnostics Device: Developers Landscape
12.1.1 Analysis by Year of Establishment
12.1.2 Analysis by Company Size
12.1.3 Analysis by Region
12.2 Global Infertility Diagnostics Device: Product Landscape
12.2.1 Analysis by Type
12.2.2 Analysis by Platform
*Additional insights are not provided in the standard report.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.